0000899243-21-021419.txt : 20210601 0000899243-21-021419.hdr.sgml : 20210601 20210601193308 ACCESSION NUMBER: 0000899243-21-021419 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210528 FILED AS OF DATE: 20210601 DATE AS OF CHANGE: 20210601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eichenfield Lawrence CENTRAL INDEX KEY: 0001814892 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38052 FILM NUMBER: 21987234 MAIL ADDRESS: STREET 1: C/O FORTE BIOSCIENCES, INC. STREET 2: 1124 W. CARSON ST., MRL BLDG 3-320 CITY: TORRANCE STATE: CA ZIP: 90502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Forte Biosciences, Inc. CENTRAL INDEX KEY: 0001419041 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261243872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1124 W CARSON STREET STREET 2: MRL BUILDING 3-320 CITY: TORRANCE STATE: CA ZIP: 90502 BUSINESS PHONE: (310) 618-6994 MAIL ADDRESS: STREET 1: 1124 W CARSON STREET STREET 2: MRL BUILDING 3-320 CITY: TORRANCE STATE: CA ZIP: 90502 FORMER COMPANY: FORMER CONFORMED NAME: Tocagen Inc DATE OF NAME CHANGE: 20071120 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-28 0 0001419041 Forte Biosciences, Inc. FBRX 0001814892 Eichenfield Lawrence C/O FORTE BIOSCIENCES, INC. 1124 W. CARSON STREET, MRL BLDG 3-320 TORRANCE CA 90502 1 0 0 0 Stock Option (right to buy) 35.54 2021-05-28 4 A 0 20000 0.00 A 2031-05-28 Common Stock 20000 20000 D Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. "Date of Grant" shall mean May 28, 2021. /s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact 2021-06-01